Earnings call transcripts

A newly appointed CEO framed fiscal 2027 as a reset focused on brand, consumer relevance, digital capabilities, and operational discipline.

Management framed FY27 as a confident but prudent growth year, with Brazilian regulatory uncertainty excluded from the plan and cost savings still ramping.

Management framed the miss as a product-learning reset, with Halloween improving trends but wholesale and traffic lowering full-year expectations.

Management framed Q2 as evidence that growth is becoming more durable through engagement, AI-enabled efficiency, and disciplined capital allocation.

Management framed FY27 as back-half weighted, with MDU deployment and pricing actions offsetting component inflation and cautious BEAD assumptions.

Management framed fiscal 2026 as an execution-led turnaround, while remaining cautious on marine recovery timing and SACStore integration investments.

Management framed the quarter as broad-based, client-led growth supported by constructive markets, while stressing continued investment and cautious capital deployment amid uncertainty.

Management framed medical as sustainably low-double-digit growth while cost savings support profitability, but industrial software remains pressured by cautious customers.

Management framed the quarter as evidence of broadening tech demand and stronger execution, while emphasizing new profit streams and a leadership handoff.

Management framed the quarter as proof that improved traffic, assortment, and store execution are creating durable operating momentum.

The call framed near-term losses as temporary manufacturing friction while emphasizing domestic backlog, policy leverage, and selective project monetization.

The call framed improving earnings quality as a mix of BBM momentum, BEC margin discipline and AI-led productivity, while raising its long-term profit ambition.